Epoetin alfa or darbepoetin alfa for chemo-related anaemia?

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2005年 / 1080卷 / 1期
关键词：
Weekly Dose; Darbepoetin Alfa; Retrospective Observational Study; Current Medical Research; Uniform Dose;
D O I：
10.2165/00128415-200510800-00009
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4 / 4
相关论文
共 50 条
  • [21] Therapeutic interchange of darbepoetin alfa for epoetin alfa in a multiinstitution health care system
    Adamson, R
    Lew, I
    Allen, P
    Misuro, A
    Malacrida, P
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (22) : 2416 - 2419
  • [22] Comment on:: The relative dosing of epoetin alfa and darbepoetin alfa in chronic kidney disease
    Einarson, Thomas
    Machado, Marcio
    Walker, John
    Iskedjian, Michael
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (07) : 1571 - 1573
  • [23] The Impact of Methodological Approach on Cost Findings in Comparison of Epoetin Alfa with Darbepoetin Alfa
    Song, Xue
    Long, Stacey R.
    Marder, William D.
    Sullivan, Sean D.
    Kallich, Joel
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (7-8) : 1203 - 1210
  • [24] Comparison of doses of epoetin alfa and darbepoetin alfa required for maintenance of haemoglobin levels
    Pussell, BA
    Walker, R
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V258 - V259
  • [25] Conversion from Epoetin Alfa to Darbepoetin Alfa for Management of Anaemia in a Community Chronic Kidney Disease Centre A Retrospective Cohort Study
    Gobin, Jaya
    Cernii, Aura
    McLean, Rosella
    Finkelstein, Fredric O.
    Simon, David B.
    CLINICAL DRUG INVESTIGATION, 2011, 31 (02) : 113 - 120
  • [26] Conversion from Epoetin Alfa to Darbepoetin Alfa for Management of Anaemia in a Community Chronic Kidney Disease CentreA Retrospective Cohort Study
    Jaya Gobin
    Aura Cernii
    Rosella McLean
    Fredric O. Finkelstein
    David B. Simon
    Clinical Drug Investigation, 2011, 31 : 113 - 120
  • [27] Comment: The Impact of Methodological Approach on Cost Findings in Comparison of Epoetin Alfa with Darbepoetin Alfa
    Lefebvre, Patrick
    Vekeman, Francis
    Cremieux, Pierre-Yves
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (03) : 595 - 595
  • [28] Retrospective study of the appropriate utilization of epoetin alfa and darbepoetin alfa in cancer patients with anemia
    Wong, SF
    Brown, ML
    Sarkisian, R
    PHARMACOTHERAPY, 2004, 24 (10): : 1452 - 1452
  • [29] Therapeutic interchange of darbepoetin alfa for epoetin alfa for chemotherapy-induced anemia.
    Blamble, DA
    Shermock, KM
    Nesbit, TW
    Pinto, B
    Fetting, J
    PHARMACOTHERAPY, 2004, 24 (10): : 1477 - 1477
  • [30] Utilization of epoetin alfa (EPO) and darbepoetin alfa (DARB) in critically ill patients.
    Mody, S.
    Watson, S.
    McKenzie, R. S.
    Raut, M.
    CRITICAL CARE MEDICINE, 2006, 34 (12) : A131 - A131
12345